Joseph Lin, MD
Cardiovascular Disease · Minneapolis, MNNPI 1184667248
Payments from drug & device makers
Across 174 payments — averaging $438.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$35K
- Boston Scientific$23K
- Abbott$18K
- Atricure, Inc.$96
- Biotronik Inc.$58
- Cardiva Medical, Inc.$29
- plus $108 from 6 others
What the payments were for
- Consulting fees$21,87538%
- Speaking & faculty fees$30,15053%
- Travel & lodging$6001%
- Food & beverage$4,7238%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 69 | $34,845 |
| Boston Scientific | 55 | $23,109 |
| Abbott | 40 | $18,057 |
| Atricure, Inc. | 1 | $96 |
| Biotronik Inc. | 2 | $58 |
| Cardiva Medical, Inc. | 1 | $29 |
| Cook Medical LLC | 1 | $24 |
| Biosense Webster, Inc. | 1 | $21 |
| Abiomed | 1 | $18 |
| Philips North America LLC | 1 | $16 |
| Vertical Pharmaceuticals, LLC | 1 | $15 |
| Impulse Dynamics (USA) Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EP-WorkMate Claris System$8,736
- WATCHMAN Access System$5,126
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$4,761
- Arctic Front$3,350
- Ensite Cardiac Mapping System$2,028
- EnSite Precision Cardiac Mapping System$1,652
- ENSITE$353
- ARCTIC FRONT ADVANCE$247
- ACCENT$179
- RF Conductr$165
- ATTAIN COMMAND + SUREVALVE$151
- Farapulse$150
- GENERAL EP$146
- ENSITE PRECISION$136
- PulseSelect$133
- WATCHMAN FLX$116
- Watchman$107
How this compares
$76,303 in reported general payments places this provider in the 75th percentile of 451 cardiovascular disease providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 101 | $111,304 |
| XareltoRivaroxaban | 35 | $48,346 |
| Metoprolol Succinate | 161 | $2,735 |
| Flecainide Acetate | 73 | $2,365 |
| SotalolSotalol Hcl | 118 | $1,929 |
| Amiodarone Hcl | 95 | $1,503 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 71 | $889 |
| ClopidogrelClopidogrel Bisulfate | 87 | $715 |
| Furosemide | 48 | $364 |
| Warfarin Sodium | 24 | $336 |
| Metoprolol Tartrate | 22 | $325 |
| Atorvastatin Calcium | 25 | $316 |
| Carvedilol | 22 | $300 |
| Colchicine | 39 | $262 |
| Rosuvastatin Calcium | 15 | $250 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Minneapolis
- Jeffrey ChambersMinneapolis$3.6M
- Thomas KnickelbineMinneapolis$1.6M
- Tamas AlexyMinneapolis$1.5M
- Joao CavalcanteMinneapolis$1.4M
- Daniel DuprezMinneapolis$1.2M
- Markus MeyerMinneapolis$1.1M
- Thenappan ThenappanMinneapolis$809K
- Mario GoesslMinneapolis$770K
- David Miranda HerreraMinneapolis$760K
- Yader Sandoval PichardoMinneapolis$701K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.